Skip to main content

Table 2 Comparison of median PFS time after apatinib treatment between patients with different clinical features (months)

From: Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours

Variable

PFS

χ2

P

ECOG

 1

2.0(0.3–15.1)

  

 2

2.2(0.2–3.1)

5.434

0.060

  ≥ 3

1.2(0.2–1.4)

  

Sex

 Male

2.1(0.2–15.1)

0.753

0.326

 Female

1.4(0.2–6.2)

  

Treatment lines

 first-line

1.3(0.2–3.1)

  

 second-line

2.3(0.9–3.1)

1.932

0.246

 third-line

1.5(0.2–15.1)

  

metastatic sites

  < 3

2.3(0.2–15.1)

3.234

0.068

  ≥ 3

1.4(0.2–2.6)

  
Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us